#Clincal

Delighted to share our view on the use of #interferons #lambda #IFNL #TYPEIII #IFN as #therapeutics against #Covid_19 #SARSCoV2. This opinion comes form an amazing team effort. #openaccess 1/5 http://doi.org/10.1084/JEM.20200653

A thread on our research pre-printed yesterday (not peer-reviewed) on the prevalence in England of antibodies against the virus that causes COVID-19. Full paper below 1/nhttps://www.imperial.ac.uk/media/imperial-college/institute-of-global-